Upgrade to SI Premium - Free Trial

Mylan N.V. (MYL) Announces U.S. Launch of Tadalafil Tablets USP 20mg, First Generic for Eli Lilly's (LLY) Adcirca Tablets

August 13, 2018 11:06 AM
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the first ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Management Comments

Next Articles